HRGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HRGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Harvard Apparatus Regenerative Technology's cost of goods sold for the three months ended in Dec. 2023 was $0.01 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Dec. 2023 was $0.02 Mil.
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Harvard Apparatus Regenerative Technology's Gross Margin % for the three months ended in Dec. 2023 was 82.54%.
Cost of Goods Sold is also directly linked to Inventory Turnover. Harvard Apparatus Regenerative Technology's Inventory Turnover for the three months ended in Dec. 2023 was 0.21.
The historical data trend for Harvard Apparatus Regenerative Technology's Cost of Goods Sold can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cost of Goods Sold | Get a 7-Day Free Trial | - | - | - | - | 0.02 |
Harvard Apparatus Regenerative Technology Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cost of Goods Sold | Get a 7-Day Free Trial | - | - | - | 0.01 | 0.01 |
Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.
Cost of Goods Sold for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology (OTCPK:HRGN) Cost of Goods Sold Explanation
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.
Harvard Apparatus Regenerative Technology's Gross Margin % for the three months ended in Dec. 2023 is calculated as:
Gross Margin % | = | (Revenue | - | Cost of Goods Sold) | / | Revenue |
= | (0.063 | - | 0.011) | / | 0.063 | |
= | 82.54 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.
Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:
Harvard Apparatus Regenerative Technology's Inventory Turnover for the three months ended in Dec. 2023 is calculated as:
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.011 | / | 0.053 | |
= | 0.21 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.
Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.
Thank you for viewing the detailed overview of Harvard Apparatus Regenerative Technology's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.
Junli He | director | C/O NO.1, COUNTRY GARDEN ROAD, BEIJIAO TOWN, SHUNDE DISTRICT, FOSHAN F4 528300 |
James E. Shmerling | director | 975 JOHNSON FERRY ROAD, SUITE 450, ATLANTA GA 30342 |
Dst Capital Llc | 10 percent owner | C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746 |
Ronald J Packard | director | 2300 CORPORATE PARK DRIVE, HERNDON VA 20171 |
Jing Chen | director | C/O BIOSTAGE,INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 02110 |
Hong Yu | officer: President | C/O BIOSTAGE, INC. 84 OCTOBER HILL ROAD, HOLLISTON MA 01746 |
Damasio Joseph Luis Jr | officer: Chief Financial Officer | 14 NORFOLK AVENUE, SOUTH EASTON MA 02375 |
David Green | director, officer: See Remarks | C/O HARVARD BIOSCIENCE INC, 84 OCTOBER HILL ROAD, HOLLISTON MA 01746-1371 |
William Fodor | officer: Chief Scientific Officer | C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746 |
Peter A. Pellegrino | officer: Interim VP of Finance | C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746 |
Herman Sanchez | director | 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON MA 01746 |
James Mastridge | officer: See Remarks | C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746 |
Jeffrey E Young | director | 60 WESTVIEW STREET, LEXINGTON MA 02421 |
Wei Zhang | director | C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, HOLLISTON MA 01746 |
Ting Li | director | C/O BIOSTAGE, INC., 84 OCTOBER HILL RD., HOLLISTON MA 01746 |
From GuruFocus
By PRNewswire PRNewswire • 11-10-2022
By PRNewswire PRNewswire • 06-19-2022
By PRNewswire PRNewswire • 01-12-2023
By PRNewswire • 08-21-2023
By PRNewswire PRNewswire • 12-28-2022
By PRNewswire PRNewswire • 07-05-2022
By PRNewswire PRNewswire • 08-08-2022
By PRNewswire PRNewswire • 03-02-2023
By PRNewswire • 08-28-2023
By PRNewswire PRNewswire • 07-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.